OR WAIT null SECS
August 02, 2019
Glass vials have come a long way from mere commodities and are now considered an integral part of final drug product.
Protein characterization is a critical part of drug development, but as there are still limitations with available techniques, industry needs to look at technological advances to meet the specific requirements of complex molecule characterization.
Formulators of parenteral drugs must be cautious of specific considerations and challenges that arise during development and manufacture.
As patient-centered therapies and clinical trials become more important, innovation is providing more control and transparency in the way that pharmaceuticals are delivered.
August 01, 2019
Industry experts discuss the role of gene-editing techniques in regenerative medicine and cell-line development.
Biopharma industry faces production challenges as gene therapies move from clinical to commercialization.
Mass-produce cell and gene therapies presents the biopharma industry with a unique set of challenges.
Researchers in China are playing a role in advancing gene therapy development.
July 31, 2019
Neuraxpharm Group has announced it is launching its first products in the United Kingdom.
July 29, 2019
Iontas and Teva Pharmaceuticals have entered into an agreement for the application of technologies and know-how into the optimization of human antibodies to be used as biotherapeutics.